The US Bankruptcy Court approved the modified disclosure statement and liquidation plan of Omega Therapeutics, Inc. on an interim basis on June 13, 2025. The debtor had filed its disclosure statement in the Court on June 11, 2025. June 16, 2025 has been fixed as voting record date.

The deadline to vote on the plan and the plan objection deadline is July 18, 2025. The confirmation hearing for the plan has been scheduled for July 30, 2025.